In this preliminary study, we aim to apply the A/T/N biomarker classification schemeto a population of neurological patients and compare the regional tau deposition by11C-PBB3-PET imaging between patients within the AD continuum, BNindividuals and patients with SNAP. The gene discussed is MAPT; the disease is Alzheimer disease.